Dynamic modulation of matrix adhesiveness induces epithelial-to-mesenchymal transition in prostate cancer cells in 3D

被引:8
|
作者
Pol, Mugdha [1 ]
Gao, Hanyuan [2 ]
Zhang, He [2 ]
George, Olivia J. [2 ]
Fox, Joseph M. [2 ,3 ]
Jia, Xinqiao [1 ,2 ,4 ,5 ,6 ]
机构
[1] Univ Delaware, Dept Biol Sci, Newark, DE USA
[2] Univ Delaware, Dept Mat Sci & Engn, Newark, DE USA
[3] Univ Delaware, Dept Chem & Biochem, Newark, DE USA
[4] Univ Delaware, Dept Biomed Engn, Newark, DE USA
[5] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA
[6] Univ Delaware, Dept Mat Sci & Engn, 201 DuPont Hall, Newark, DE 19716 USA
关键词
Tetrazine ligation; Hydrogels; Prostate cancer; RGD; Epithelial-to-mesenchymal transition; ACID-BASED HYDROGELS; HYALURONIC-ACID; PROTEOLYTIC DEGRADATION; PERINEURAL INVASION; CORTACTIN PROMOTES; COMPLEX; BINDING; POLYMERIZATION; CYTOSKELETON; INVADOPODIA;
D O I
10.1016/j.biomaterials.2023.122180
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Synthetic matrices with dynamic presentation of cell guidance cues are needed for the development of physiologically relevant in vitro tumor models. Towards the goal of mimicking prostate cancer progression and metastasis, we engineered a tunable hyaluronic acid-based hydrogel platform with protease degradable and cell adhesive properties employing bioorthogonal tetrazine ligation with strained alkenes. The synthetic matrix was first fabricated via a slow tetrazine-norbornene reaction, then temporally modified via a diffusion-controlled method using trans-cyclooctene, a fierce dienophile that reacts with tetrazine with an unusually fast rate. The encapsulated DU145 prostate cancer single cells spontaneously formed multicellular tumoroids after 7 days of culture. In situ modification of the synthetic matrix via covalent tagging of cell adhesive RGD peptide induced tumoroid decompaction and the development of cellular protrusions. RGD tagging did not compromise the overall cell viability, nor did it induce cell apoptosis. In response to increased matrix adhesiveness, DU145 cells dynamically loosen cell-cell adhesion and strengthen cell-matrix interactions to promote an invasive phenotype. Characterization of the 3D cultures by immunocytochemistry and gene expression analyses demonstrated that cells invaded into the matrix via a mesenchymal like migration, with upregulation of major mesenchymal markers, and down regulation of epithelial markers. The tumoroids formed cortactin positive invadopodia like structures, indicating active matrix remodeling. Overall, the engineered tumor model can be utilized to identify potential molecular targets and test pharmacological inhibitors, thereby accelerating the design of innovative strategies for cancer therapeutics.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
    Ablin, Richard J.
    Owen, Sioned
    Jiang, Wen G.
    ANTICANCER RESEARCH, 2017, 37 (02) : 481 - 487
  • [2] ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells
    Rodgers, Jamie J.
    McClure, Robert
    Epis, Michael R.
    Cohen, Ronald J.
    Leedman, Peter J.
    Harvey, Jennet M.
    Thomas, Marc A.
    Bentel, Jacqueline M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (01) : 848 - 860
  • [3] Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
    Fontana, Fabrizio
    Raimondi, Michela
    Marzagalli, Monica
    Sommariva, Michele
    Limonta, Patrizia
    Gagliano, Nicoletta
    CELLS, 2019, 8 (02)
  • [4] FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
    Liu, Hao
    Yin, Jiang
    Wang, Hongsheng
    Jiang, Guanmin
    Deng, Min
    Zhang, Ge
    Bu, Xianzhang
    Cai, Shaohui
    Du, Jun
    He, Zhimin
    CELLULAR SIGNALLING, 2015, 27 (03) : 510 - 518
  • [5] Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
    Kolijn, Kimberley
    Verhoef, Esther I.
    van Leenders, Geert J. L. H.
    ONCOTARGET, 2015, 6 (27) : 24488 - 24498
  • [6] Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer
    Verrill, Clare
    Cerundolo, Lucia
    Mckee, Chad
    White, Michael
    Kartsonaki, Christiana
    Fryer, Eve
    Morris, Emma
    Brewster, Simon
    Ratnayaka, Indrika
    Marsden, Luke
    Lilja, Hans
    Muschel, Ruth
    Lu, Xin
    Hamdy, Freddie
    Bryant, Richard J.
    ONCOTARGET, 2016, 7 (02) : 1107 - 1119
  • [7] Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors
    Wu, Kaijie
    Zeng, Jin
    Li, Lei
    Fan, Jinhai
    Zhang, Dong
    Xue, Yan
    Zhu, Guodong
    Yang, Lin
    Wang, Xinyang
    He, Dalin
    ONCOLOGY REPORTS, 2010, 23 (06) : 1545 - 1552
  • [8] The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
    Lo, U-Ging
    Lee, Cheng-Fan
    Lee, Ming-Shyue
    Hsieh, Jer-Tsong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [9] Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells
    Kim, Chul Jang
    Sakamoto, Kanami
    Tambe, Yukihiro
    Inoue, Hirokazu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (06) : 1759 - 1766
  • [10] MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells
    Ceppi, P.
    Peter, M. E.
    ONCOGENE, 2014, 33 (03) : 269 - 278